NEULAND LABORATORIES
Back to Cashflow Statement
|
NEULAND LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹21 Cr | ₹25 Cr | ₹-69 Cr | ₹-136 Cr | ₹38 Cr |
What is the latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹21 Cr |
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹-69 Cr |
| Mar2023 | ₹-136 Cr |
| Mar2022 | ₹38 Cr |
How is Cash Flow from Financing Activities of NEULAND LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹21 Cr | -15.97 | |
| Mar2025 | ₹25 Cr | Positive | |
| Mar2024 | ₹-69 Cr | Negative | |
| Mar2023 | ₹-136 Cr | Negative | |
| Mar2022 | ₹38 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹29,838.7 Cr | 5% | 24.2% | 80.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 5% |
24.2% |
80.9% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses